The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 2, 1996, Pages 315-322

  Koukourakis, Michael ^a   Hlouverakis, Gregory ^a   Kosma, Laira ^b   Skarlatos, John ^b   Damilakis, John ^a   Giatromanolaki, Alexandra ^a   Yannakakis, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Nonsmall cell lung cancer; Normalized total dose; Overall treatment time; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; DOSE CALCULATION; DOSE RESPONSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0030034739     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02102-7     Document Type: Article

References (25)

1. Cox, J. D.; Azarnia, N.; Byhardt, R. W.; Shin, K. H.; Emami, B.; Perez, C. A. N2 (clinical) non small cell carcinoma of the lung: Prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 20:7-12; 1991.
2. Curren, W. J.; Stafford, P. M. Lack of apparent differences in outcome between clinically staged IIIA and IIIB non small cell lung cancer treated with radiation therapy. J. Clin. Oncol. 8:409-415; 1990.
3. Emami, B.; Perez, C. A.; Herskovich, A.; Hederman, M. A. Phase I/II study of treatment of locally advanced (T3,T4) non oat cell lung cancer with high dose radiotherapy (rapid fractionation): Radiation Therapy Oncology Study. Int. J. Radiat. Oncol. Biol. Phys. 15:1021-1025; 1988.
4. Emami, B.; Perez, C. A. Carcinoma of the lung. In: Perez, C. A.; Brady, L. W., eds. Principles and practice of radiation oncology, 2nd ed. Philadelphia, PA: Lippincott Co.; 1987:650-699.
5. Enstrom, J. E.; Austin, D. F. Interpreting cancer survival rates. Science 195:847-851; 1977.
6. Fisher, J. J.; Fisher, D. B. The determination of time-dose relationship from clinical data. Br. J. Radiol. 44:785-791; 1971.
7. Hendry, J. H. Treatment acceleration in radiotherapy: The relative time factors and dose response slopes for tumours and normal tissues. Radiother. Oncol. 25:308-312; 1992.
8. Hermane, K. P.; Sobin, L. H. UICC, TNM classification of malignant tumours. 4th ed. Berlin: Springer Verlag; 1988.
9. Johnson, D. H.; Einhorn, L. H.; Bartolucci, A.; Birch, R.; Omura, G.; Perez, C. A. Thoracic radiotherapy does not prolong survival in patients with locally advanced unresectable non small cell lung cancer. Ann. Intern. Med. 113:33-38; 1990.
10. Koukourakis, M.; Damilakis, J. LQ-based model for biological radiotherapy planning. Med. Dosim. 19:269-277; 1994.
11. Koukourakis, M.; Skarlatos, J.; Kosma, L.; Giatromanolaki, A.; Yannakakis, D. Radiotherapy alone for non small cell lung carcinoma. Five-year disease free survival and patterns of failure. Acta Oncol. 34:525-530; 1995.
12. Maciejewski, B.; Preuss-Beyer, G.; Trott, K. R. The influence of number of fractions and overall treatment time on the local tumour control of cancer of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 9:321-328; 1983.
13. Maciejewski, B.; Majewski, S. Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother. Oncol. 21:163-170; 1991.
14. Noordijk, E. M.; vd Poest Clement, E.; Hermans, J.; Wever, A. M.; Leer, J. W. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother. Oncol. 14:89-94; 1989.
15. Overgaard, M.; Hjem-Hansen, M.; Vandelbo, J. L.; Anderson, A. P. Comparison of conventional and split course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27:147-161; 1988.
16. Payne, D. G. Non small cell lung cancer: Should unresectable stage III patients receive high dose radiation therapy? J. Clin. Oncol. 6:552-558; 1988.
17. Porter, E. H. The statistics of dose/cure relationships for irradiated tumours. Br. J. Radiol. 53:210-214; 1980.
18. Roberts, S. A.; Hendry, J. H. The delay before onset of accelerated tumor repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection world-wide tumour control data. Radiother. Oncol. 29:69-74; 1993.
19. Saunders, M. I.; Dische, S. Continues hyperfractionated, accelerated radiotherapy (CHART) in non small cell carcinoma of the bronchus. Int. J. Radiat. Oncol. Biol. Phys. 19:1211-1215; 1990.
20. Slevin, N. J.; Hendry, J. H.; Roberts, S. A.; Sgren-Cronqvist, A. The effect of increasing the treatment time beyond three weeks on control of T2 and T3 laryngeal cancer using radiotherapy. Radiother. Oncol. 24:215-220; 1992.
21. Stanley, K. E. Lung cancer and tobacco: A global problem. Cancer Detect. Prevent. 9:83-89; 1986.
22. Talton, B. M.; Constable, W. C.; Kersh, C. R. Curative radiotherapy in non small cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 19:15-21; 1990.
23. Taylor, J. M. G.; Withers, H. R.; Mendenhall, W. M. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother. Oncol. 17:95-102; 1990.
24. Withers, H. R.; Taylor, J. M. G.; Maciejewski, B. The hazard of accelerated tumour clonogene repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.
25. Zhang, H. X.; Yin, W. B.; Zhang, L. J.; Yang, Z. Y.; Zhang, X. Z.; Wang, M.; Chen, D. F.; Gu, X. Z. Curative radiotherapy of early operable non small cell lung cancer. Radiother. Oncol. 13:83-89; 1988.